Copyright
©The Author(s) 2017.
World J Gastroenterol. May 7, 2017; 23(17): 3053-3065
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3053
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3053
Figure 4 CXCL12/CXCR7 expression in intestinal-type gastric cancer and diffuse-type gastric cancer.
A: CXCL12 expression in lymph node metastasis of intestinal-type gastric cancer; B: CXCL12 expression in lymph node metastasis of diffuse-type gastric cancer; C: CXCL12 expression showed no significant difference between lymph node metastasis of intestinal-type and diffuse-type gastric cancer; D: CXCR7 expression in lymph node metastasis of intestinal-type gastric cancer; E: CXCR7 expression in lymph node metastasis of diffuse-type gastric cancer; F: CXCR7 expression showed no significant difference between lymph node metastasis of intestinal-type and diffuse-type gastric cancer. aP > 0.05.
- Citation: Xin Q, Zhang N, Yu HB, Zhang Q, Cui YF, Zhang CS, Ma Z, Yang Y, Liu W. CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma. World J Gastroenterol 2017; 23(17): 3053-3065
- URL: https://www.wjgnet.com/1007-9327/full/v23/i17/3053.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i17.3053